LabCompass

Publications

199

Citations

1,958

Est. group size

~1

Recurring co-author estimate

Active years

21

Publishing since 2006

Research summary
AI-generated

Heba M. Ismail studies type 1 diabetes, a condition where the body's immune system attacks the insulin-producing cells of the pancreas. The work focuses on tracking how the disease develops and progresses, using blood-based markers (such as metabolites linked to gut bacteria) and models of pancreatic beta-cell function, and applying tools like machine learning to predict key turning points. Related projects examine gut microbiome influences on metabolic health and biomarkers for detecting infection in newborns.

Type 1 diabetes progression and predictionBeta-cell function and metabolic modelingGut microbiota and metabolomicsMachine learning for disease predictionBiomarkers for neonatal infection

Publication activity has grown steadily over the last decade, rising from a handful per year to roughly 30 per year in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 24.2/year recently
2017: 2 publications172018: 15 publications182019: 10 publications192020: 15 publications202021: 19 publications212022: 20 publications222023: 31 publications232024: 34 publications34242025: 32 publications252026: 4 publications26
Recent publications
Publishes in
  • Diabetes×55
  • Communications Medicine×16
  • Diabetes Care×14
  • medRxiv×8
  • Diabetologia×6

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile